Chemotherapy for Breast Cancer: 738 Real Stories

738 stories match breast cancer and chemotherapy. 653 of them mention surgery.

Anne, who was diagnosed with Stage III Breast CancerBreast Cancer

Stage III Triple-Negative Breast Cancer: Anne's Survivor Story

Patient Info: Anne, Female | Stage III

Biomarkers: ER-negative; PR-negative; HER2-negative

Anne completed chemotherapy during pregnancy, double mastectomy, radiotherapy, and additional chemotherapy for Stage III metaplastic triple-negative breast cancer and described using the experience as a source of personal transformation.

breastcancer.org
OutcomeSurvivorship / Completed Treatment
Kattysmith, who was diagnosed with Stage IV Breast CancerBreast Cancer

Stage IV Breast Cancer: Kattysmith's Patient Story

Patient Info: Kattysmith, Female, 60s | Stage IV

Metastatic Site: lymphatic system; skin/soft-tissue nodules; possible…

After AC chemotherapy, the metastatic nodules shrank markedly. Kattysmith was stable on palbociclib and letrozole with declining tumor markers, while clearly stating that she was not NED.

breastcancer.org
OutcomeResponding Well
Naomi, who was diagnosed with Breast CancerBreast Cancer

Breast Cancer: Naomi's Patient Story

Patient Info: Naomi, Female

After chemotherapy, mastectomy, and radiation, Naomi remained in ongoing infusion treatment while managing heart failure and other serious treatment complications. Metastatic disease was discussed in a chart note but was later rejected by her oncologist and is not treated as confirmed.

breastcancer.org
OutcomeCare Ongoing
Adriana, who was diagnosed with Breast CancerBreast Cancer

Breast Cancer: Adriana's Survivor Story

Patient Info: Adriana, Female, Under 40

After chemotherapy, surgery, and radiotherapy, Adriana returned to Israel, married, and began considering ways to become a mother.

breastcancer.org
OutcomeSurvivorship / Completed Treatment
Ann, who was diagnosed with Stage IV Invasive Lobular CarcinomaBreast Cancer

Stage IV HR-Positive Invasive Lobular Carcinoma: Ann's Patient Story

Patient Info: Ann, Female | Stage IV

Biomarkers: ER-positive; HER2-negative

Metastatic Site: peritoneum; intestines/bowel

Ann was living with metastatic invasive lobular breast cancer involving the peritoneum and bowel. After 9 months of recurrence treatment, she underwent successful ileostomy reversal and regained greater freedom to travel.

breastcancer.org
OutcomeLiving With Cancer
Jenna, who was diagnosed with Breast CancerBreast Cancer

HR-Positive Breast Cancer: Jenna's Patient Story

Patient Info: Jenna, Female, Under 40

Biomarkers: ER-positive

Jenna completed 10 rounds of chemotherapy and double mastectomy for ER-positive breast cancer with lymph-node involvement. She was recovering, planning reconstruction, and preparing for long-term tamoxifen.

breastcancer.org
OutcomeCare Ongoing
Suzi, who was diagnosed with Breast CancerBreast Cancer

Breast Cancer: Suzi's Patient Story

Patient Info: Suzi, Female

Suzi completed lumpectomy, weekly chemotherapy, and radiation and remained on Herceptin every 3 weeks through September 2025. She had not yet been declared to have no evidence of disease.

breastcancer.org
OutcomeCare Ongoing
Susan, who was diagnosed with Stage III Breast CancerBreast Cancer

Stage III Breast Cancer: Susan's Survivor Story

Patient Info: Susan, Female, 50s | Stage III

Susan completed surgery, chemotherapy, and radiation for Stage III breast cancer and described herself as a 10-year survivor.

breastcancer.org
OutcomeSurvivorship / Completed Treatment
A patient, who was diagnosed with Stage IV Breast CancerBreast Cancer

Hormone receptor-positive, HER2-positive breast cancer with later lung metastasis

Patient Info: Anonymized, Female | Stage IV

Biomarkers: Hormone receptor-positive; HER2-positive

Metastatic Site: Lung

The patient had hormone receptor-positive, HER2-positive breast cancer treated with standard therapy, then developed lung metastasis years later and continued molecular targeted therapy indefinitely while asymptomatic from the metastasis.

AZ Oncology Japan
OutcomeLiving With Cancer
Regina, who was diagnosed with Stage IV Breast CancerBreast Cancer

Stage IV HER2-Positive Breast Cancer: Regina's Patient Story

Patient Info: Regina Ritter, Female, 50s | Stage IV

Biomarkers: HER2-positive

Metastatic Site: Liver | Lung

At the 2013 interview, Regina was living with metastatic HER2-positive breast cancer after liver metastasis at diagnosis, later recurrence, and inoperable lung metastasis treated with oral chemotherapy.

Krankheitserfahrungen.de
OutcomeLiving With Cancer
Leftfootforward, who was diagnosed with Stage IV Breast CancerBreast Cancer

Stage IV HER2-Positive Breast Cancer: Leftfootforward's Survivor Story

Patient Info: Leftfootforward, Female, Under 40 | Stage IV

Biomarkers: HER2-positive

Metastatic Site: Brain | Liver

Leftfootforward was diagnosed with Stage IIB HER2-positive breast cancer in 2010 and metastatic brain/liver disease in 2012; after systemic therapy, Gamma Knife, craniotomy for necrotic tissue, partial liver lobectomy, and resumed Herceptin, her latest scans showed no evidence of disease.

BreastCancer.org (ES)
OutcomeCancer-Free / NED
Rachel, who was diagnosed with Stage IV Breast CancerBreast Cancer

Stage IV Breast Cancer: Rachel's Patient Story

Patient Info: Rachel, Female | Stage IV

Rachel was living with Stage 4 breast cancer for 12 years with hormone treatment, oral chemotherapy, and CT/MRI scans every 3 months; she described her health as very good.

The Christie NHS
OutcomeLiving With Cancer
Carol, who was diagnosed with Breast CancerBreast Cancer

Breast Cancer: Carol's Survivor Story

Patient Info: Carol, Female

Carol completed breast cancer treatment at age 30, later had 2 children, and 30 years later no longer needed Christie check-ups.

The Christie NHS
OutcomeCancer-Free / NED
Iria, who was diagnosed with Breast CancerBreast Cancer

Breast Cancer: Iria's Survivor Story

Patient Info: Iria, Female, Under 40

Iria completed a 10-month breast cancer treatment course that included chemotherapy and participation in a clinical trial with experimental therapy.

Roche España Historias
OutcomeSurvivorship / Completed Treatment
Susana, who was diagnosed with Breast CancerBreast Cancer

BRCA Breast Cancer: Susana's Survivor Story

Patient Info: Susana, Female

Biomarkers: BRCA mutation

Susana was finishing treatment after bilateral mastectomy and delayed chemotherapy complicated by wound-healing problems and allergic reactions.

Roche España Historias
OutcomeSurvivorship / Completed Treatment
Gemina, who was diagnosed with Breast CancerBreast Cancer

Breast Cancer: Gemina's Survivor Story

Patient Info: Gemina, Female

Gemina completed surgery followed by prolonged chemotherapy, radiotherapy, and biological therapies, overcame the disease, and later became pregnant with her first child.

Roche España Historias
OutcomeCancer-Free / NED
Carolina, who was diagnosed with Stage IV Breast CancerBreast Cancer

Stage IV BRCA Breast Cancer: Carolina's Patient Story

Patient Info: Carolina, Female | Stage IV

Biomarkers: BRCA mutation

Metastatic Site: Not specified

Carolina had metastatic breast cancer from the start, completed bilateral mastectomy, multiple surgeries, 6 months of chemotherapy, and 25 radiation sessions, and still had reconstructive procedures remaining.

Roche España Historias
OutcomeCare Ongoing
Belén, who was diagnosed with Breast CancerBreast Cancer

Breast Cancer: Belén's Survivor Story

Patient Info: Belén, Female

Belén completed mastectomy, chemotherapy through December 2007, and 5 years of hormone therapy, and later attended follow-up visits calmly and confidently.

Roche España Historias
OutcomeSurvivorship / Completed Treatment
Marta, who was diagnosed with Breast CancerBreast Cancer

Breast Cancer: Marta's Survivor Story

Patient Info: Marta, Female, Under 40

Marta completed a 5-year breast cancer treatment path that included surgery, 6 months of chemotherapy, radiotherapy, hormone therapy, and clinical trial participation.

Roche España Historias
OutcomeSurvivorship / Completed Treatment
Pilar, who was diagnosed with Stage IV Breast CancerBreast Cancer

Stage IV HER2-Positive Breast Cancer: Pilar's Patient Story

Patient Info: Pilar, Female, 40s | Stage IV

Biomarkers: Hormone receptor-positive; HER2-positive

Pilar was living with metastatic hormone receptor-positive, HER2-positive breast cancer, continuing systemic treatment with Zoladex, aromatase inhibitors, trastuzumab, and pertuzumab, and managing side effects with rehabilitation support.

MatchTrial Historias Reales
OutcomeLiving With Cancer
Ana, who was diagnosed with Breast CancerBreast Cancer

Breast Cancer: Ana's Patient Story

Patient Info: Ana, Female, 40s

Biomarkers: Hormone-dependent tumor

Ana completed surgery, 6 months of chemotherapy, and 16 radiation sessions for hormone-dependent breast cancer and continued Tamoxifen plus quarterly Zoladex as recurrence-prevention therapy.

MatchTrial Historias Reales
OutcomeCare Ongoing
Cindy-Anne, who was diagnosed with Breast CancerBreast Cancer

Breast Cancer: Cindy-Anne's Survivor Story

Patient Info: Cindy-Anne Manoo, Female, 40s

Cindy-Anne completed mastectomy with reconstruction, second surgery, chemotherapy, and 15 radiation sessions after her initial Stage I breast cancer surgery was followed by positive lymph-node and margin findings.

BreastCancer.org (ES)
OutcomeSurvivorship / Completed Treatment
Toni, who was diagnosed with Breast CancerBreast Cancer

HR-Positive Breast Cancer: Toni's Patient Story

Patient Info: Toni S, Female, 50s

Biomarkers: ER-positive or PR-positive; HER2-positive; triple-positive breast cancer

Toni completed chemotherapy, surgery, Kadcyla, and radiation for triple-positive breast cancer with lymph-node involvement and continued anastrozole to suppress estrogen.

BreastCancer.org (ES)
OutcomeCare Ongoing
Stephanie, who was diagnosed with Stage II Invasive Ductal CarcinomaBreast Cancer

Stage II BRCA1 Invasive Ductal Carcinoma: Stephanie's Patient Story

Patient Info: Stephanie Hargis, Female, Under 40 | Stage II

Biomarkers: ER-negative; PR-negative; HER2-negative; BRCA1 mutation

Stephanie had Stage II triple-negative breast cancer with BRCA1 mutation, then a local recurrence in April 2023 without distant spread; after surgery, chemotherapy, Keytruda, radiation, and Lynparza, she remained in ongoing post-recurrence treatment.

BreastCancer.org (ES)
OutcomeCare Ongoing